V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002096 | 240006897 | 1.59 | 64.6 | null | null | 2020-08-11 | null | 02 | null | RITUXIMAB | 101337720 |
| 240002100 | 240006898 | 1.64 | 96 | 03 | 2016-04-27 | 2016-05-01 | Azacitidine | null | N | AML19 TRIAL | 100747234 |
| 240002104 | 240006901 | 1.74 | 116.5 | null | 2017-11-22 | 2017-11-22 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100562153 |
| 240002108 | 240006903 | null | null | 03 | 2020-08-20 | 2020-08-20 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101342749 |
| 240002109 | 240006904 | 1.84 | 74 | 03 | null | 2019-05-14 | null | 02 | N | METHOTREXATE | 100399769 |
| 240002113 | 240006907 | 1.57 | 118 | null | null | 2017-11-15 | null | 01 | null | HYDROXYCARBAMIDE | 101832225 |
| 240002116 | 240006908 | 1.69 | 84 | 03 | null | 2020-05-20 | null | 02 | null | AZACITIDINE | 100380209 |
| 240002120 | 240006911 | null | null | null | 2018-06-07 | 2018-06-07 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100442270 |
| 240002123 | 240006913 | null | null | Curative (C) | null | 2021-05-15 | null | null | N | METHOTREXATE | 101713967 |
| 240002132 | 240006915 | 1.57 | 89.8 | null | null | 2022-04-13 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 101136001 |
| 240002134 | 240006917 | 1.62 | 60 | Curative (C) | 2018-02-16 | 2018-02-16 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100183450 |
| 240002139 | 240006920 | 1.63 | 0 | null | null | 2020-04-18 | null | 02 | null | METHOTREXATE | 101165821 |
| 240002143 | 240006922 | null | null | Adjuvant (A) | 2017-10-19 | 2017-10-21 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101238689 |
| 240002144 | 240006923 | 1.54 | 77.6 | null | null | 2019-07-17 | null | 02 | null | AML19 TRIAL | 100133154 |
| 240002145 | 240006924 | 0 | 92.35 | null | 2019-06-02 | 2019-06-02 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100157753 |
| 240002153 | 240006928 | 1.84 | 62.8 | Curative (C) | 2019-03-03 | 2019-03-11 | AML 18 TRIAL | 02 | null | AML19 TRIAL | 100732469 |
| 240002156 | 240006929 | null | null | null | 2017-08-16 | 2017-08-17 | Hydroxycarbamide | null | null | HYDROXYCARBAMIDE | 101594026 |
| 240002157 | 240006930 | 1.73 | 101 | null | null | 2020-08-24 | null | 02 | null | AML19 TRIAL | 101846235 |
| 240002158 | 240006931 | null | null | Curative (C) | 2020-04-10 | 2020-04-20 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100360214 |
| 240002160 | 240006933 | 1.52 | 76.6 | null | null | 2016-05-29 | null | N | null | RITUXIMAB | 100300505 |
| 240002162 | 240006934 | 1.57 | 64.25 | Curative (C) | 2022-02-21 | 2022-03-07 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100282861 |
| 240002165 | 240006937 | 1.65 | 101 | Curative (C) | null | 2017-11-19 | null | 02 | N | METHOTREXATE | 101611649 |
| 240002170 | 240006941 | 1.6 | 80.1 | null | null | 2020-12-21 | null | 02 | null | AML18 TRIAL | 100938995 |
| 240002172 | 240006943 | 1.78 | 119.3 | Curative (C) | null | 2022-04-07 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 101672433 |
| 240002180 | 240006947 | 1.6 | 115.5 | Palliative (P) | null | 2021-02-02 | null | null | N | AZACITIDINE | 100463085 |
| 240002186 | 240006950 | null | null | null | null | 2021-05-11 | null | N | N | HYDROXYCARBAMIDE | 101485933 |
| 240002189 | 240006952 | 1.67 | 47.8 | Adjuvant (A) | null | 2020-03-17 | null | 01 | null | AML19 TRIAL | 100197632 |
| 240002197 | 240006955 | 1.7 | 78.6 | null | 2021-03-31 | 2022-04-05 | AML 18 TRIAL | null | null | AML19 TRIAL | 101344732 |
| 240002198 | 240006956 | 1.7 | 95 | null | 2018-01-15 | 2018-01-20 | Hydroxycarbamide | 01 | N | HYDROXYCARBAMIDE | 101753296 |
| 240002199 | 240006957 | 1.73 | 63 | null | null | 2021-03-16 | null | null | null | AML19 TRIAL | 101817798 |
| 240002201 | 240006958 | 1.77 | 70.65 | null | null | 2020-11-06 | null | 02 | null | CYTARABINE | 101430526 |
| 240002204 | 240006959 | 1.68 | 60 | null | null | 2018-11-04 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 101625150 |
| 240002209 | 240006962 | 1.66 | 72.2 | null | 2019-08-13 | 2019-08-25 | AML 19 TRIAL | 02 | null | AML19 TRIAL | 100826087 |
| 240002215 | 240006965 | 1.63 | 76.4 | 03 | 2022-02-16 | 2022-02-19 | Rituximab | 02 | null | RITUXIMAB | 100383551 |
| 240002216 | 240006966 | 1.73 | null | null | null | 2020-08-24 | null | 02 | null | RITUXIMAB | 100326439 |
| 240002221 | 240006968 | null | null | Palliative (P) | 2018-04-12 | 2018-04-14 | AML 18 TRIAL | N | N | HYDROXYCARBAMIDE | 101811879 |
| 240002222 | 240006969 | 1.58 | 46.6 | null | null | 2021-12-20 | null | null | N | AML19 TRIAL | 101586362 |
| 240002228 | 240006971 | 1.82 | 81 | Curative (C) | null | 2019-10-10 | null | null | N | METHOTREXATE | 101252329 |
| 240002234 | 240006975 | 1.53 | 24.6 | null | null | 2019-11-07 | null | N | null | METHOTREXATE | 101496504 |
| 240002235 | 240006976 | 0 | 91 | null | 2020-04-14 | 2020-04-17 | AML 18 TRIAL | null | null | HYDROXYCARBAMIDE | 101542308 |
| 240002241 | 240006979 | 1.63 | 75 | Curative (C) | null | 2019-06-23 | null | 02 | N | RITUXIMAB | 100540022 |
| 240002242 | 240006980 | 1.84 | 81 | null | 2021-08-07 | 2021-08-07 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100737207 |
| 240002244 | 240006981 | null | 15.4 | Palliative (P) | 2018-04-19 | 2018-04-19 | Hydroxycarbamide | 01 | N | HYDROXYCARBAMIDE | 101044798 |
| 240002247 | 240006983 | null | null | 03 | 2020-08-17 | 2020-08-17 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101541957 |
| 240002251 | 240006986 | 1.58 | 50 | null | null | 2017-04-10 | FLAIR trial | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100816566 |
| 240002253 | 240006987 | null | null | null | 2018-06-08 | 2018-06-09 | null | 02 | null | NOT MATCHED | 100254580 |
| 240002255 | 240006989 | 1.56 | 95.4 | null | 2020-10-19 | 2020-10-20 | null | 01 | null | TRIAL | 100543161 |
| 240002256 | 240006990 | 1.54 | 89.5 | null | null | 2020-01-17 | FLAG + Idarubicin | null | null | CARMUSTINE + THIOTEPA | 101531033 |
| 240002257 | 240006991 | 1.74 | 52 | 03 | 2018-03-31 | 2018-04-02 | IVE-R | 02 | N | ALL INT GDE 2019 MAINTENANCE | 101473545 |
| 240002260 | 240006993 | 1.71 | 14.9 | null | 2018-01-20 | 2018-01-21 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100126269 |